Objective To identify the 140‐kd autoantigen recognized by anti‐155/140 autoantibodies that
are associated with adult cancer‐associated dermatomyositis (DM) and juvenile DM and to …

Objectives Myositis-specific autoantibodies (MSAs) are useful tools for identifying clinically
homogeneous subsets and predicting prognosis of patients with idiopathic inflammatory …

The so-called “Fourth Industrial revolution”, also termed as “Industry 4.0” in the wider literature,
is associated with several cutting-edge technologies. Indicative examples in this category …

Objectives Myositis-specific autoantibodies (MSAs) define distinct clinical subsets of idiopathic
inflammatory myopathies (IIMs). The anti-nuclear matrix protein 2 (NXP2) antibody, a …

Use of immune checkpoint inhibitors that target programmed cell death-1 (PD-1) can lead to
various autoimmune-related adverse events (irAEs) including psoriasis-like dermatitis. Our …

The content and composition of triterpene alcohol fractions of the non-saponifiable lipids (NSL)
along with the fatty acid composition of the kernel fats (n-hexane extracts) of the shea …

Objectives To investigate whether autoimmunity to transcriptional intermediary factor 1 (TIF1)γ,
a ubiquitous nuclear autoantigen for myositis-specific autoantibodies detected in patients …

Designing Massive Open Online Courses (MOOCs) involve new challenges for instructional
designers. In particular, the unknown number of participants and the range of diverse needs …

Anti-melanoma differentiation–associated gene 5 (MDA5) antibody–positive dermatomyositis
(DM) is characterized by amyopathic DM with interstitial lung disease (ILD). Patients with …

Langerhans cells (LCs) are skin-resident cells with potent antigen-presenting cell capabilities,
which reportedly play some roles in the development of psoriasis, an inflammatory skin …